Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)
Completed · Phase 3
Conditions studied: Asthma
In brief
Typically, people with asthma are initially prescribed a low dose of inhaled corticosteroid (ICS) medication to control asthma symptoms. If a low dose of ICS is ineffective at controlling symptoms, the addition of a second controller medication is recommended. This study will examine the effectiveness of the medication tiotropium bromide combined with a low dose of ICS at maintaining asthma control in people with moderately severe asthma.
Key facts
- Study ID
- NCT00565266
- Run by
- Milton S. Hershey Medical Center
- People needed
- 210
- Starts
- 2008-05-01
- Expected to finish
- 2010-05-01
- Last updated by the study team
- 2018-07-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California, San Diego — San Diego, California, United States
- University of California, San Francisco — San Francisco, California, United States
- National Jewish Medical and Research Center — Denver, Colorado, United States
- Brigham & Women's Hospital — Boston, Massachusetts, United States
- Washington University, St. Louis — St Louis, Missouri, United States
- Columbia University Health Sciences — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
- University of Texas Medical Branch — Galveston, Texas, United States
- University of Wisconsin, Madison — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.